German Wolf Attacks ‘Spiraling Out of Control,’ Farm Lobby Warns
(Bloomberg) -- The number of wolf attacks in Germany is spiraling out of control and having a “devastating” impact on livestock farmers, according to the industry's lobby group.
Almost 2,900 animals, most of them sheep and goats, were injured or killed in wolf attacks in 2019, the DBV farmers' association said Wednesday, citing figures from a government body that researches wolves. While environmental groups welcome the increase in the animal's numbers in the wild, the DBV called for urgent action to address the issue.
“The tactic of trivializing and minimizing the massive damage is irresponsible,” Bernhard Kruesken, the DBV's general secretary, said in a statement. “We must now finally get down to the serious regulation of wolf populations.”
Wolves disappeared from Germany about 150 years ago before the animals were sighted again around the turn of the century. Their population has since grown to 109 packs, with an additional 29 couples and 11 single wolves, DBBW data show.
Read more: Wolves Approach Paris as Farmers Cry Foul Over Protected Species
“Most wolf attacks on farm animals occur where wolves have just established themselves in new territories and the sheep and goat farmers have not yet adjusted to their presence,” according to the DBBW. “Usually the damage in these areas decreases after one or two years” when animal owners have learned to deal with their presence.
Germany's lower house of parliament approved legislation in December that eased rules on killing wolves, allowing farmers to shoot them if they cause “serious damage” to livestock.
©2020 Bloomberg L.P.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Swiggy vs Eternal: Food Delivery's Two Rivals Are No Longer In The Same Race
Eternal is building a private AI assistant, dark.ai. Swiggy is still working out how to make Instamart pay, with an operating loss of Rs 895 crore in the July-September quarter while Blinkit stayed profitable.
-
Where You Live Shapes How You Get To Work | The Reason Why
Two-wheelers are the most popular way to get to work in India, accounting for nearly 43% of workplace commutes.
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.